- Home
- BFRI vs CELZ Comparison
BFRI vs CELZ Comparison
Compare BFRI & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- CELZ
- Stock Information
- Founded
- BFRI 1997
- CELZ 1998
- Country
- BFRI United States
- CELZ United States
- Employees
- BFRI N/A
- CELZ N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- BFRI Health Care
- CELZ Health Care
- Exchange
- BFRI Nasdaq
- CELZ Nasdaq
- Market Cap
- BFRI 7.9M
- CELZ 7.4M
- IPO Year
- BFRI 2021
- CELZ N/A
- Fundamental
- Price
- BFRI $0.84
- CELZ $3.31
- Analyst Decision
- BFRI Strong Buy
- CELZ
- Analyst Count
- BFRI 1
- CELZ 0
- Target Price
- BFRI $2.75
- CELZ N/A
- AVG Volume (30 Days)
- BFRI 347.9K
- CELZ 128.9K
- Earning Date
- BFRI 08-13-2025
- CELZ 08-08-2025
- Dividend Yield
- BFRI N/A
- CELZ N/A
- EPS Growth
- BFRI N/A
- CELZ N/A
- EPS
- BFRI N/A
- CELZ N/A
- Revenue
- BFRI $39,188,000.00
- CELZ $6,000.00
- Revenue This Year
- BFRI $11.07
- CELZ N/A
- Revenue Next Year
- BFRI $11.20
- CELZ N/A
- P/E Ratio
- BFRI N/A
- CELZ N/A
- Revenue Growth
- BFRI 11.20
- CELZ N/A
- 52 Week Low
- BFRI $0.54
- CELZ $1.69
- 52 Week High
- BFRI $2.22
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- BFRI 42.93
- CELZ 57.11
- Support Level
- BFRI $0.82
- CELZ $3.09
- Resistance Level
- BFRI $0.95
- CELZ $3.37
- Average True Range (ATR)
- BFRI 0.07
- CELZ 0.17
- MACD
- BFRI -0.01
- CELZ -0.00
- Stochastic Oscillator
- BFRI 20.70
- CELZ 73.19
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.